News

How can EMAV address the evolving challenges in animal health in future best?

In recent months core activities of EMAV included the close consultation of EMAV in particular with the European Commission in the changed process and timeline for the implementation of the Reg. (EU) 2019/6 and for the publication of a GMP standard for autogenous vaccines, the work on new EMAV projects, like for rationales for the EMAV GMP proposal, for a new EMAV ROADMAP and for epidemiological issues and the admission of new EMAV members, Dr. Klaus-Peter Behr, Chairman of the association, reported at the annual meeting in May in Berlin.

06.06.2025

New members welcomed and Executive Board completed at the EMAV General Assembly in May in Berlin

At the association's annual meeting, Klaus-Peter Behr, Chairman of EMAV, welcomed two new EMAV members, Syva from Spain and FILAVIE from France.

11.05.2025

The implementation of the new Animal Health Law for autogenous vaccines – new aspects discussed by EMAV in Barcelona

At an EMAV-Workshop session end of April in Barcelona experts for the manufacturing and use of autogenous vaccines (AV) from all over Europe discussed aspects and expected consequences in the implementation of Reg. (EU) 2019/6 for AV thoroughly – based on the presentations “Expected next steps and timelines for the development of a GMP guideline for AV by EMA/GMDP IWG” by António Azevedo (Senior Scientific Specialist GMP, Quality and Safety of Medicines Department, European Medicines Agency).

30.04.2024

A unique Manual of Autogenous Vaccines has been published by EMAV!

The Association of European Manufacturers of Autogenous Vaccines and Sera, EMAV, has published a comprehensive Manual of Autogenous Vaccines. This unique publication was prepared by well recognised scientists from veterinary universities in Europe, experienced veterinary experts and specialists from the circle of EMAV member companies.

08.09.2023

Important aspects in the process of implementation of Regulation (EU) 2019/6 for autogenous vaccines discussed by EMAV in Paris

At an EMAV General Assembly and Workshop EMAV members made use of the opportunity to discuss aspects of the implementation of the new EU Animal Health law in a guidance especially dedicated for the manufacturing and use of autogenous vaccines with acknowledged experts from European authorities.

28.06.2023